LIN vs USBC
Linde plc Ordinary Shares (LIN) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. USBC currently screens at market cap $0.
Not investment advice. Open the LIN and USBC stock pages for the full models.
Not investment advice.